Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$63.64 - $125.14 $1.16 Million - $2.27 Million
-18,165 Reduced 99.59%
75 $5,000
Q2 2024

Aug 09, 2024

SELL
$101.21 - $166.61 $2,024 - $3,332
-20 Reduced 0.11%
18,240 $2.17 Million
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $30,818 - $41,673
361 Added 2.02%
18,260 $1.95 Million
Q4 2023

Jan 23, 2024

BUY
$69.51 - $104.43 $1.24 Million - $1.87 Million
17,899 New
17,899 $1.78 Million
Q1 2023

Apr 18, 2023

BUY
$135.66 - $197.02 $124,942 - $181,455
921 Added 12.69%
8,178 $1.26 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $12,903 - $22,894
-109 Reduced 1.48%
7,257 $1.3 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $2,479 - $4,077
21 Added 0.29%
7,366 $974,000
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $6,676 - $10,065
57 Added 0.78%
7,345 $1.05 Million
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $64,494 - $119,875
510 Added 7.52%
7,288 $1.26 Billion
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $8,355 - $13,634
37 Added 0.55%
6,778 $1.72 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $1.68 Million - $3.67 Million
-7,580 Reduced 52.93%
6,741 $2.59 Million
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $959,255 - $1.74 Million
-7,384 Reduced 34.02%
14,321 $3.37 Million
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $57,982 - $149,816
-882 Reduced 3.9%
21,705 $2.27 Million
Q3 2020

Nov 10, 2020

SELL
$54.34 - $94.85 $36,896 - $64,403
-679 Reduced 2.92%
22,587 $1.6 Million
Q2 2020

Aug 10, 2020

BUY
$29.67 - $80.0 $690,302 - $1.86 Million
23,266 New
23,266 $1.49 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track R Pg Family Wealth Advisory, LLC Portfolio

Follow R Pg Family Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.